This is the English edition. 한국어판 and 日本語版 are also available.
A U.S.-focused analysis of Anthropic’s 30-plus biomolecular-model optimizations, FlashPairformer, low-memory Big mode, GPU cost claims and the limits that still require independent reproduction.
2026-09-26·Source Anthropic
A U.S. comparison of OpenAI’s GPT-Rosalind and Rosalind Workbench with Anthropic’s life-science lab and early ART enzyme result, including access, cost and validation limits.
2026-09-26·Source OpenAI Developers
A close reading of Ramp’s September 2026 U.S. business payment data, including Anthropic and OpenAI adoption, falling token costs and the limits of market-share claims.
2026-09-25·Source Ramp
A U.S.-focused analysis of Anthropic’s 130-person research survey, productivity claims and what AI-assisted AI development means for oversight, science and safety.
2026-09-25·Source Anthropic
A precise analysis of Anthropic’s four unauthorized third-party access incidents, the misconfigured evaluation environment and what its 481-million-record review can establish.
2026-09-25·Source Anthropic
